Cardiac steatosis in patients with dilated cardiomyopathy

Marit Granér1, Markku O Pentikäinen1, Kristofer Nyman2

  • 1Division of Cardiology, Diabetes and Obesity Research Program, Heart and Lung Center, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.

Insights

In patients with dilated cardiomyopathy (DCM), myocardial fat (triglyceride) content was lower, while epicardial and pericardial fat were higher. This suggests a specific role for fat metabolism in heart failure.

Area of Science:

  • Cardiology
  • Metabolic Research
  • Medical Imaging

Background:

  • Ectopic fat accumulation, particularly cardiac steatosis, is linked to increased cardiovascular disease risk.
  • Limited data exists on cardiac adiposity in patients diagnosed with dilated cardiomyopathy (DCM).

Purpose of the Study:

  • To investigate the components of cardiac steatosis in non-diabetic DCM patients.
  • To explore the relationship between cardiac fat depots and left ventricular (LV) structure and function.

Main Methods:

  • Utilized 1.5 Tesla magnetic resonance spectroscopy (MRS) to measure myocardial and hepatic triglyceride (TG) content.
  • Employed MRI to assess LV function, visceral adipose tissue (VAT), abdominal subcutaneous tissue (SAT), and epicardial and pericardial fat.
  • Compared 10 non-diabetic men with DCM against 20 healthy controls.

Main Results:

  • Patients with DCM exhibited significantly lower myocardial TG content compared to controls (0.41% vs. 0.86%).
  • Epicardial (895 mm² vs. 664 mm²) and pericardial fat depots were significantly larger in DCM patients.
  • LV global function index was more severely reduced in DCM patients than LV ejection fraction (EF).

Conclusions:

  • Non-diabetic DCM subjects showed decreased myocardial TG and increased epicardial/pericardial fat.
  • Altered myocardial TG content appears to play a specific role in myocardial energy metabolism within the context of congestive heart failure.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826